# FDA 483 - Noble Pharma, LLC - August 22, 2025

Source: https://www.keypedia.com/records/483/noble-pharma-llc/ecb7beef-f833-48b1-9251-cdd991f47a54

> FDA 483 for Noble Pharma, LLC on August 22, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Noble Pharma, LLC
- Inspection Date: 2025-08-22
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: Noble Pharma, LLC, a pharmaceutical manufacturer, was cited for significant deficiencies in its quality system. The inspection revealed a failure to record and investigate deviations from written production and process control procedures, including issues noted in batch records and an instrument malfunction. This indicates a lack of adequate control over manufacturing processes and laboratory operations.

## Related Documents

- [483 - Unknown Date](https://www.keypedia.com/records/483/noble-pharma-llc/bc71bd7c-3765-4391-beed-b399aece1c1f)
- [483 - 2025-03-06](https://www.keypedia.com/records/483/noble-pharma-llc/c04e1180-5007-41e7-b4e4-bfa5b00c9d91)

## Related Officers

- [Supreet K. Sran](https://www.keypedia.com/people/supreet-k-sran/1dab51f8-b483-4ccb-8b44-89fdc3b8100b)
- [Elizabeth R. Bloom](https://www.keypedia.com/people/elizabeth-r-bloom/51c7ec4e-97bb-4543-adc3-cf02d335f159)
- [Gurpreet K Gran](https://www.keypedia.com/people/gurpreet-k-gran/83791ba8-2834-4350-8825-1c4a95bf2e90)
- [ Investigator ](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.keypedia.com/companies/noble-pharma-llc/7fd1f37f-ba04-49a3-a115-ad7110e9f8a5

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d